Erwin Dreesen
Has grant
Professor at KU Leuven
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Erwin Dreesen is a Professor at KU Leuven in Belgium. His research focuses on population pharmacokinetics, particularly in geriatric patients and those with chronic illnesses. Recent topics of interest include the optimization of drug therapies in patients with atrial fibrillation, inflammatory bowel disease, and invasive candidiasis. He is also involved in developing tools for handling missing data in pharmacometrics modeling.
Recent Grants
Grant: Close
Pharmacometric models for improved therapeutic drug monitoring of ceftriaxone, posaconazole and infliximab
Open Date: 2019-10-01
Close Date:
Positions (1)
Erwin Dreesen
KU Leuven
8 months ago
The Leuven Pharmacometrics Research Group at KU Leuven, led by Prof. Erwin Dreesen, is offering a fully funded PhD position in Quantitative Pharmacology of Biologics. The group is part of the Clinical Pharmacology and Pharmacotherapy Unit within the Department of Pharmaceutical and Pharmacological Sciences, and is internationally recognized for its expertise in data-driven modeling and simulation (M&S) to advance drug development and precision medicine. Research areas span immune-mediated inflammatory diseases, infectious diseases, transplantation, and oncology. This PhD project focuses on developing a computational platform model for biologic therapies, integrating data from clinical trials and real-world studies. The aim is to simulate and evaluate optimized dosing strategies for special populations, including hard-to-treat patients. The project is embedded in a flexible academic–industry collaboration, providing opportunities for scientific exploration, innovation, and direct impact on model-informed drug development in line with emerging regulatory frameworks. The successful candidate will join a dynamic, supportive, and international research environment with English as the primary working language. The position offers access to state-of-the-art infrastructure, high-performance computing, and dedicated training programs to enhance expertise. There are ample opportunities for interdisciplinary collaboration, career development, and participation in regular social and networking events. KU Leuven is committed to fostering an inclusive, respectful, and diverse workplace culture. Eligibility: Applicants must have a Master’s degree in Pharmacometrics, Pharmaceutical Sciences, (Bio)medicine, (Bio)statistics, Bioinformatics, Biotechnology, Mathematics, Bioengineering, or a related field. Essential skills include experience with modeling and simulation software (e.g., NONMEM, R), statistical data analysis, programming in R and/or Python, and excellent English communication skills. Candidates should be independent, proactive, and enthusiastic about interdisciplinary research. Prior experience with PK–PD studies and a background in pharmacometrics are advantageous but not required. Funding: The position is full-time, initially for 2 years and extendable up to 4 years, with full research support, access to infrastructure, and training. The project is conducted in collaboration with industry partners. Application Window: The application deadline is 27 February 2026. For more information, contact Prof. dr. Erwin Dreesen at [email protected] . Apply online via the KU Leuven job portal using the provided link.
8 months ago
Articles (20)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (2)
An Coosemans
Katholieke Universiteit Leuven
Robin Vos, MD, PhD
Adjunct-Head of Clinic, Associate Professor
-
Make your next move.
Prepare your application
Review drafts before you send them.